The existing prediction models for severe complications of preeclampsia are most accurate only in the two days after hospital ...

Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced positive initial data from Part B of the DeFianCe study ...

FIBRONEER™-ILD was a double-blind, randomized, placebo-controlled trial evaluating the efficacy and safety of nerandomilast ...

Higher levels of leukocytes -- a form of white blood cell -- are associated with more severe symptoms of long COVID among ...

Boston-based CereVasc designed eShunt for treating normal pressure hydrocephalus (NPH). This study evaluates the technology ...

Arsenal Medical announced the completion of the initial cohort enrollment in the EMBO-02 clinical study of the company’s ...

COVID-19 vaccination is linked to a transient decrease in hyperthyroidism risk but an increase in hypothyroidism risk over 12 ...

While researchers don’t currently know why women are at greater risk of long COVID, differences in the way men’s and women’s ...

Two leading US-based autism centres have joined Blinklab’s autism diagnostic registrational trial. ... Read More The post ...

In the Central African Republic, peacekeeping missions are losing popular support by failing to meet people’s expectations, ...

A new study from the University of Suffolk is set to explore motor neurone disease (MND) and how it affects couples.